Recombinant Activated Factor VII Significantly Reduces Transfusion Requirements in Cardiothoracic Surgery

BACKGROUND: The off-label use of recombinant activated factor VII (rFVIIa) for intractable bleeding is associated with a risk of thrombotic events. The objective of this study was to evaluate the incidence and predictors of rFVIIa-related thrombotic events and its efficacy in the reduction of transf...

Descripción completa

Detalles Bibliográficos
Autores principales: Omar, Hesham R., Enten, Garrett, Karlnoski, Rachel, Ching, Yiu-Hei, Mangar, Devanand, Camporesi, Enrico M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488183/
https://www.ncbi.nlm.nih.gov/pubmed/25862216
http://dx.doi.org/10.1007/s40268-015-0093-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488183/
https://www.ncbi.nlm.nih.gov/pubmed/25862216
http://dx.doi.org/10.1007/s40268-015-0093-9

Ejemplares similares